Study shows who benefits most from statins

Study shows who benefits most from statins

New research suggests that widely used statin therapy provides the most benefit to patients with the highest genetic risk of heart attack. Using a relatively straightforward genetic analysis, the researchers, including Nathan O. Stitziel, MD, PhD, assessed heart attack risk independently of the traditional risk factors.
Washington People: Melissa Hopkins

Washington People: Melissa Hopkins

Melissa Hopkins, assistant vice chancellor and assistant dean of facilities operations at the School of Medicine, excels at multi-tasking. At work, she oversees facilities engineering, design and construction, support services, business operations and protective services. At home, she and her husband have three children with plans to adopt three more. Further, she also shares custody of three children and has three adult sons from a previous marriage.
Epigenome orchestrates embryonic development

Epigenome orchestrates embryonic development

Studying zebrafish embryos, researchers at Washington University School of Medicine in St. Louis have shown that the epigenome plays a significant part in guiding development in the first 24 hours after fertilization. The research may deepen understanding of congenital defects and miscarriage.

Investigational drug can reduce asthma flareups

An investigational drug appears to cut the risk of severe asthma attacks in half for patients who have difficulty controlling the disorder with standard medications, according to results from two multicenter clinical trials headed by Mario Castro, MD, the Alan A. and Edith L. Wolff Professor of Pulmonary and Critical Care Medicine at the School of Medicine.

Distinguished Faculty, Goldstein honors awarded

School of Medicine faculty members were honored with Distinguished Faculty Awards on Wednesday, Feb. 18, for their dedication, talent and wide-ranging achievements. Shown is D. Katherine Grange, MD, who was given a Distinguished Clinician Award, and Larry J. Shapiro, MD, executive vice chancellor for medical affairs and dean of the medical school.
Older Stories